Yubo International Biotech Ltd (YBGJ)
0.80
-0.10
(-11.10%)
USD |
OTCM |
May 17, 12:57
Yubo International Biotech Revenue (TTM): 0.6088M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6088M |
| September 30, 2023 | 0.6531M |
| June 30, 2023 | 0.2391M |
| March 31, 2023 | 0.2457M |
| December 31, 2022 | 0.1043M |
| September 30, 2022 | 0.37M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.4538M |
| March 31, 2022 | 0.7973M |
| December 31, 2021 | 1.244M |
| September 30, 2021 | 1.795M |
| June 30, 2021 | 1.891M |
| March 31, 2021 | 1.816M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.1043M
Minimum
Dec 2022
1.891M
Maximum
Jun 2021
0.8515M
Average
0.631M
Median
Revenue (TTM) Benchmarks
| Meihua International Medical Technologies Co Ltd | 97.10M |
| Hologic Inc | 3.961B |
| Nuwellis Inc | 8.895M |
| Varex Imaging Corp | 855.80M |
| Quanterix Corp | 124.70M |